Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns

Burns

Volumn 42, Issue 1, 2016, Pages 131-140

  Gholipourmalekabadi, M ^a,b   Sameni, M ^b   Hashemi, A ^a   Zamani, F ^c   Rostami, A ^a   Mozafari, M ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MATERIALS AND ENERGY RESEARCH CENTER   (Iran)

Author keywords

Antibacterial activity; Bioactive glass; Fluoride; Silver; Wound healing

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BIOACTIVE GLASS; CALCIUM; CARBENICILLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COPPER; FLUORIDE; FLUORIDE ION; GENTAMICIN; GLASS; IMIPENEM; MEROPENEM; OXYGEN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SILICON; SILVER DERIVATIVE; TOBRAMYCIN; UNCLASSIFIED DRUG; ZINC; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; PENICILLANIC ACID; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION; SILVER; THIENAMYCIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; BURN; CELL VIABILITY; CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFICACY; ESCHERICHIA COLI; FEASIBILITY STUDY; FIBROBLAST; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOUSE; NIH 3T3 CELL LINE; WOUND INFECTION;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; AZTREONAM; BURNS; CARBENICILLIN; CEFTAZIDIME; CEFTRIAXONE; CELL SURVIVAL; CEPHALOSPORINS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUORIDES; GENTAMICINS; GLASS; HUMANS; IMIPENEM; MICE; MICROBIAL SENSITIVITY TESTS; NIH 3T3 CELLS; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; SILVER; THIENAMYCINS; TOBRAMYCIN; WOUND INFECTION;

EID: 84951049066     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2015.09.010     Document Type: Article

References (49)

1. L.A. Barajas-Nava, J. López-Alcalde, M. Roqué i Figuls, I. Solà, and X. Bonfill Cosp Antibiotic prophylaxis for preventing burn wound infection 2013 The Cochrane Library
2. M. Panghal, K. Singh, S. Kadyan, U. Chaudary, and J. Yadav The analysis of distribution of multidrug resistant Pseudomonas and Bacillus species from burn patients and burn ward environment Burns 2014
3. D. Church, S. Elsayed, O. Reid, B. Winston, and R. Lindsay Burn wound infections Clinical Microbiol Rev 19 2006 403 434
4. G. Gravante, D. Delogu, and G. Sconocchia "Systemic apoptotic response" after thermal burns Apoptosis 12 2007 259 270
5. J.S. Glasser, C.H. Guymon, K. Mende, S.E. Wolf, D.R. Hospenthal, and C.K. Murray Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients Burns 36 2010 1172 1184
6. U. Altoparlak, S. Erol, M.N. Akcay, F. Celebi, and A. Kadanali The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients Burns 30 2004 660 664
7. N. Agnihotri, V. Gupta, and R. Joshi Aerobic bacterial isolates from burn wound infections and their antibiograms - a five-year study Burns 30 2004 241 243
8. F.N. Williams, D.N. Herndon, H.K. Hawkins, J.O. Lee, R.A. Cox, G.A. Kulp, and et al. The leading causes of death after burn injury in a single pediatric burn center Crit Care 13 2009 R183
9. P.-R. Hsueh, L.-J. Teng, P.-C. Yang, Y.-C. Chen, S.-W. Ho, and K.-T. Luh Persistence of a multidrug-resistant pseudomonas aeruginosa clone in an intensive care burn unit J Clin Microbiol 36 1998 1347 1351
10. M.J. Ellington, J. Kistler, D.M. Livermore, N. Woodford, and P.C.R. Multiplex for rapid detection of genes encoding acquired metallo-β-lactamases J Antimicrob Chemother 59 2007 321 322
11. G. Cornaglia, H. Giamarellou, and G.M. Rossolini Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis 11 2011 381 393
12. Y. Miyajima, K. Hiramatsu, E. Mizukami, R. Morinaga, H. Ishii, R. Shirai, and et al. In vitro and in vivo potency of polymyxin B against IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa Int J Antimicrob Agents 32 2008 437 440
13. D. Campoccia, L. Montanaro, and C.R. Arciola A review of the biomaterials technologies for infection-resistant surfaces Biomaterials 34 2013 8533 8554
14. A. Rostami, M. Mozafari, M. Gholipourmalekabadi, H.H. Caicedo, Z. Lasjerdi, M. Sameni, and et al. Optimization of fluoride-containing bioactive glasses as a novel scolicidal agent adjunct to hydatid surgery Acta Trop 148 2015 105 114
15. M.S. Mohammadi, and C. Stähli Bioactive glasses for wound healing Bioactive glasses: materials, properties and applications 2011 246
16. M. Mozafari, and F. Moztarzadeh Silver-doped bioactive glasses: what remains unanswered? InterCeram: Int Ceram Rev 62 2013 423 425
17. M. Mozafari Bioceramics in the realm of history Bioceram Dev Appl 4 2014 e106 10.4172/2090-5025.1000e106
18. A. Lansdown, B. Sampson, P. Laupattarakasem, and A. Vuttivirojana Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat Br J Dermatol 137 1997 728 735
19. A. Lansdown, A. Williams, S. Chandler, and S. Benfield Silver absorption and antibacterial efficacy of silver dressings J Wound Care 14 2005 155 160
20. 5 sol-gel derived bioactive glass Key Eng Mater 493 2012 74 79
21. M. Gholipourmalekabadi, N. Nezafati, L. Hajibaki, M. Mozafari, F. Moztarzadeh, S. Hesaraki, and et al. Detection and qualification of optimum antibacterial and cytotoxic activities of silver-doped bioactive glasses IET Nanobiotechnol 2015
22. M. Rai, A. Yadav, and A. Gade Silver nanoparticles as a new generation of antimicrobials Biotechnol Adv 27 2009 76 83
23. P. Tatar, N. Kiraz, M. Asiltürk, F. SayIlkan, H. SayIlkan, and E. Arpaç Antibacterial thin films on glass substrate by sol-gel process J Inorg Organomet Polym Mater 17 2007 525 533
24. J. Schierholz, L. Lucas, A. Rump, and G. Pulverer Efficacy of silver-coated medical devices J Hosp Infect 40 1998 257 262
25. S.M. Lee, B.S. Lee, T.G. Byun, and K.C. Song Preparation and antibacterial activity of silver-doped organic-inorganic hybrid coatings on glass substrates Colloids Surf A: Physicochem Eng Asp 355 2010 167 171
26. M.M. Bioceramics in the realm of history Bioceram Dev Appl 4 2014 e106
27. 2O-doped bioactive glass Antimicrob Agents Chemother 46 2002 1940 1945
28. Q. Feng, J. Wu, G. Chen, F. Cui, T. Kim, and J. Kim A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus J Biomed Mater Res 2001 662 668
29. 2 thin films by sol-gel method Biomaterials 24 2003 4921 4928
30. M. Gholipourmalekabadi, M. Mozafari, M. Salehi, A. Seifalian, M. Bandehpour, H. Ghanbarian, and et al. Development of a cost-effective and simple protocol for decellularization and preservation of human amniotic membrane as a soft tissue replacement and delivery system for bone marrow stromal cells Adv Healthcare Mater 4 2015 918 926
31. M. Gholipourmalekabadi, M. Bandehpour, M. Mozafari, A. Hashemi, H. Ghanbarian, M. Sameni, and et al. Decellularized human amniotic membrane: more is needed for an efficient dressing for protection of burns against antibiotic-resistant bacteria isolated from burn patients Burns 2015
32. M.H. Vala, M. Hallajzadeh, F. Fallah, A. Hashemi, and H. Goudarzi Characterization of the extended-spectrum beta-lactamase producers among non-fermenting Gram-negative bacteria isolated from burnt patients Arch Hyg Sci 2013 2
33. G.P. Wormser, and C. Stratton Manual of clinical microbiology P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Landry, M.A. Pfaller, Clinical infectious diseases vol. 46 2008 ASM Press Washington, DC 153 2007 2488 pp. (hardcover)
34. CLSI C Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI/NCCLS Document M100-S22 2012 Clinical and Laboratory Standards Institute Wayne, PA
35. M. Gholipourmalekabadi, M. Mozafari, M. Bandehpour, M. Salehi, M. Sameni, H.H. Caicedo, and et al. Optimization of nanofibrous silk fibroin scaffolds as a delivery system for bone marrow adherent cells Biotechnol Appl Biochem 2014
36. M. Gholipourmalekabadi, M. Mozafari, M. Gholipourmalekabadi, M. Nazm Bojnordi, M.B. Hashemi-soteh, M. Salimi, and et al. In vitro and in vivo evaluations of three-dimensional hydroxyapatite/silk fibroin nanocomposite scaffolds Biotechnol Appl Biochem 2015
37. F. Fallah, A. Taherpour, R. Borhan, A. Hashemi, M. Habibi, and R.S. Nia Evaluation of Zataria MultiFlora Boiss and Carum copticum antibacterial activity on IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa Ann Burns Fire Disasters 26 2013 193
38. Y. Arakawa, M. Murakami, K. Suzuki, H. Ito, R. Wacharotayankun, S. Ohsuka, and et al. A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP Antimicrob Agents Chemother 39 1995 1612 1615
39. R.E. Mendes, M.A. Toleman, J. Ribeiro, H.S. Sader, R.N. Jones, and T.R. Walsh Integron carrying a novel metallo-(-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac (6′)-30/aac (6′)-Ib′: report from the SENTRY Antimicrobial Surveillance Program Antimicrob Agents Chemother 48 2004 4693 4702
40. 2 thin film with high concentration Curr Appl Phys 9 2009 1381 1385
41. J.K. Hongslo, and R.I. Holland Effect of sodium fluoride on protein and DNA synthesis, ornithine decarboxylase activity, and polyamine content in LS cells Acta Pharmacol Toxicol 44 1979 350 353
42. 5 glass in simulated body fluid J Non-Cryst Solids 356 2010 1470 1478
43. M. Nourmohammadzadeh, J.F. Lo, M. Bochenek, J.E. Mendoza-Elias, Q. Wang, Z. Li, and et al. Microfluidic array with integrated oxygenation control for real-time live-cell imaging: effect of hypoxia on physiology of microencapsulated pancreatic islets Anal Chem 85 23 2013 11240 11249
44. J.R.J. Delben, O.M. Pimentel, M.B. Coelho, P.D. Candelorio, L.N. Furini, F. Alencar dos Santos, and et al. Synthesis and thermal properties of nanoparticles of bioactive glasses containing silver J Therm Anal Calorim 97 2009 433 436
45. M.G. Page, and K. Bush Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising? Curr Opin Pharmacol 18 2014 91 97
46. F. Duan, X. Li, S. Cai, G. Xin, Y. Wang, D. Du, and et al. Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I J Med Chem 57 2014 3707 3714
47. M. Kawashita, S. Tsuneyama, F. Miyaji, T. Kokubo, H. Kozuka, and K. Yamamoto Antibacterial silver-containing silica glass prepared by sol-gel method Biomaterials 21 2000 393 398
48. A. Balamurugan, G. Balossier, D. Laurent-Maquin, S. Pina, A. Rebelo, J. Faure, and et al. An in vitro biological and anti-bacterial study on a sol-gel derived silver-incorporated bioglass system Dent Mater 24 2008 1343 1351
49. A. Wren, N.M. Cummins, and M. Towler Comparison of antibacterial properties of commercial bone cements and fillers with a zinc-based glass polyalkenoate cement J Mater Sci 45 2010 5244 5251